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Abstract
Background: Uncoupling protein 2 (UCP2) is a mitochondrial transporter that has been shown to lower the production of
reactive oxygen species (ROS). Intracellular pathogens such as Leishmania upregulate UCP2 and thereby suppress ROS
production in infected host tissues, allowing the multiplication of parasites within murine phagocytes. This makes host
UCP2 and ROS production potential targets in the development of antileishmanial therapies. Here we explore how UCP2
affects the outcome of cutaneous leishmaniosis (CL) and visceral leishmaniosis (VL) in wild-type (WT) C57BL/6 mice and in
C57BL/6 mice lacking the UCP2 gene (UCP2KO).
Methodology and Findings: To investigate the effects of host UCP2 deficiency on Leishmania infection, we evaluated
parasite loads and cytokine production in target organs. Parasite loads were significantly lower in infected UCP2KO mice
than in infected WT mice. We also found that UCP2KO mice produced significantly more interferon-c (IFN-c), IL-17 and IL-13
than WT mice (P,0.05), suggesting that UCP2KO mice are resistant to Leishmania infection.
Conclusions: In this way, UCP2KO mice were better able than their WT counterparts to overcome L. major and L. infantum
infections. These findings suggest that upregulating host ROS levels, perhaps by inhibiting UPC2, may be an effective
approach to preventing leishmaniosis.
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Introduction
UCP2 is a mitochondrial carrier expressed in a wide variety of
tissues, including white adipose tissue, skeletal muscle and the
immune system [1]. UCP2 activity presumably lowers the
efficiency of oxidative phosphorylation by increasing the mem-
brane proton conductance. This effect would result in an increased
rate of respiration leading to a downregulation of the mitochon-
drial production of ROS. This uncoupling activity is widely
considered as an additional element of the cellular antioxidant
defence [2–4]. In fact, UCP2 is upregulated in many pathological
processes in which ROS play an important role in the
development of the disease (atherosclerosis, cancer, chronic
inflammation, etc.) [2]. In addition, UCP2 has been postulated
to help regulation of insulin secretion by pancreatic b-cells [5].
Indeed, loss-of-function mutations of UCP2 have been identified
in patients suffering from congenital hyperinsulinism. It has been
shown that UCP2 modulates glucose-stimulated insulin secretion
by reducing mitochondrial ROS [6].
By decreasing ROS production, UCP2 may weaken the
immune system when faced with attack by bacterial and parasitic
pathogens. Mice lacking UCP2 showed higher survival rates than
WT mice following experimental infection with Listeria monocyto-
genes [7] or Toxoplasma gondii [8]. A recent in vitro study de-
monstrated that Leishmania donovani upregulates UCP2 and
thereby suppresses mitochondrial ROS production, leading to
increased production of anti-inflammatory cytokines and parasite
survival inside murine macrophages [9]. The same authors found
that silencing UCP2 in vivo in splenic tissue of BALB/c mice 3
days prior to L. donovani infection stimulates ROS production,
shifts the balance of pro- vs. anti-inflammatory cytokines towards
the pro-inflammatory phenotype and reduces splenic parasite
burden after 4–6 weeks of infection. These findings raise the
possibility of targeting host UCP2 activity and ROS production
as a strategy to develop effective therapies against leishmaniosis.
To make this work possible, the role that host UCP2 plays in the
host immune response to Leishmania infection should first be
investigated in vivo.
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The leishmaniases comprise a group of diseases caused by
infection by several species of intracellular protozoan parasites of
the genus Leishmania, which are transmitted by the bite of an
infected female phlebotomine sandfly [10]. Infections with L. major
and L. infantum are distinguished by clinical manifestations ranging
from localized skin ulcers at the site of the sandfly bite (CL), to
potentially lethal visceral disease (VL), respectively. The leishman-
iases represent a global public health problem, affecting an
estimated 12 million people around the world. Indeed, 1.5 million
new cases of CL and 0.5 million new cases of VL are reported in
humans each year [11]. Current research has focused on the
development of diagnostic methods, drugs and vaccines. Unfor-
tunately, despite considerable progress, treatments are toxic and
expensive [12] and no vaccines are available for any form of
human leishmaniosis [13,14]. The leishmaniases are classified as
neglected tropical diseases (NTDs), which still require improved
treatment strategies and new prophylactic vaccines [15].
To investigate the role of UCP2 in host immune defense against
intracellular pathogens, we explored in detail the outcomes of CL
and VL due to L. major and L. infantum infection of WT C57BL/6
mice and UCP2 knockout (UCP2KO) C57BL/6 mice. Infection was
analyzed in vivo by measurement of footpad swelling, quantification
of parasite load and assays for the production of cytokines and
Leishmania-specific antibodies. Better understanding of the role of
host UCP2 in the immune response to Leishmania parasites should
help develop more effective strategies to control disease.
Materials and Methods
Ethics statement
The animal research described in this manuscript complied with
Spanish (Ley 32/2007) and European Union legislation (2010/
63/UE). The protocols used were approved by the Animal Care
Committee of Complutense University of Madrid.
Animals
C57BL/6 mice were purchased from Harlan Interfauna Ibe´rica
(Barcelona, Spain). UCP2KO mice with a C57BL/6 background
were obtained from JAX mice (The Jackson Laboratory, Bar
Harbor, USA). In infection experiments, mice were matched for
age and sex (females, 8–9 weeks old).
Parasites and preparation of soluble antigen
L. major parasites (clone V1: MHOM/IL/80/Friedlin) and L.
infantum parasites (MCAN/ES/96/BCN/150, MON-1) were
cultured at 26uC in Schneider’s medium (Sigma-Aldrich, Madrid,
Spain) containing 20% heat-inactivated fetal calf serum (FCS,
Sigma-Aldrich), streptomycin and penicillin. Soluble Leishmania
antigen (SLA) was prepared from stationary cultures of L. major
promastigotes as previously described [16]. Leishmania pifanoi
axenic amastigote strain MHOM/VE/60/Ltrod (kindly provided
by A. A. Pan, The Johns Hopkins School of Hygiene and Public
Health, Baltimore, Maryland 21205, USA) was cultured at 32uC
in M199 medium supplemented with 20% heat-inactivated FCS,
2.5% (w/v) trypticase peptone, 13.8 mM D-glucose, 76 mM hemin,
and 48 mg/mL gentamicin sulfate at pH 7.2 [17].
Preparation of peritoneal macrophages
Three days after intraperitoneal injection of 1 ml of 4%
thioglycollate (Difco Laboratories, Detroit, MI), cells were
obtained by peritoneal lavage with cold phosphate-buffered saline
(PBS). Then cells were washed and plated as needed for each
experiment in RPMI medium containing 10% heat-inactivated
FCS.
Carboxyfluorescein succinimidyl ester (CFSE) labeling of
L. pifanoi and in vitro infection
L. pifanoi amastigotes were labeled using the fluorescent dye
CFSE (Invitrogen, San Diego, CA). Briefly, parasites were
incubated in PBS at 46106 parasites/ml CFSE (0.4 mg/ml) for
30 min at 32uC. This process does not affect parasite multiplica-
tion [18]. To evaluate intracellular killing of L. pifanoi amastigotes
we seeded peritoneal macrophages onto LabTek culture chamber
incubation slides (Thermo Scientific, Madrid, Spain) at 56104 per
chamber. On the following day, adherent macrophages were
incubated for 4 h with L. pifanoi amastigotes in the ratio 4:1. Then
cells were washed until all free parasites were removed. After 24 h,
confocal images were acquired using a confocal laser scanning
microscope (Leica TCS – SP2 ABOS), and the infection rate was
assessed by counting both the number of infected macrophages
and the number of parasites per infected macrophage.
Fluorescent detection of mitochondrial ROS
ROS production in peritoneal macrophages isolated from
UCP2KO and WT mice was estimated from the rate of
fluorescence increase of the cell-permeant redox-sensitive fluores-
cent indicators dihydroethidium (DHE) and 29,79-dichlorodihy-
drofluorescein diacetate (DCFDA). Cells (256103 per well) were
seeded in 96-well plates in RPMI containing 10% FCS. When
required, 4 h before the determination, macrophages were
infected with L. pifanoi at a ratio 3:1 and incubated at 32uC in
RPMI without FCS and phenol red. After the incubation, plates
were transferred to a Varioskan Flash microplate reader and the
fluorescent probe of interest added to each well. Fluorescence
intensity was recorded for 50 min, with measurements every
2 min, and the maximum rate of fluorescence increase calculated
after subtraction of the rate obtained in the absence of cells. The
rate of hydrogen peroxide formation was estimated with the probe
DCFDA (10 mM, excitation 485 nm, emission 535 nm) and the
rate of superoxide formation with the probe DHE (50 mM,
excitation 535 nm, emission 610 nm).
Author Summary
The leishmaniases comprise a group of diseases caused by
infection by several species of intracellular protozoan
parasites of the genus Leishmania, which are transmitted
by the bite of an infected sandfly. The leishmaniases
represent a global public health problem, affecting an
estimated 12 million people around the world and ranging
from self-healing skin lesions to potentially fatal systemic
infections. Here, we use mouse models of CL and VL to
investigate the effect of a host gene called UCP2.
Uncoupling protein 2 (UCP2) is a mitochondrial carrier
expressed in a wide variety of tissues, including white
adipose tissue, skeletal muscle and the immune system.
Intracellular pathogens such as Leishmania upregulate
UCP2 and may weaken the immune system. Consequently,
parasites survive and multiply within mouse macrophages.
We demonstrate here that mice lacking the UCP2 gene are
better able than WT mice to control both CL and VL.
Infection was analyzed in vivo by measurement of footpad
swelling, quantification of parasite load and assays for the
production of cytokines and Leishmania-specific antibod-
ies. These findings could have important implications in
designing an effective approach to preventing leishman-
iosis.
Host UCP2, ROS Production and Leishmania Infection
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NO release and IL-12 p40 production by uninfected and
infected macrophages
To measure NO release, peritoneal macrophages were plated at
56104 per well in 96-well plates in the presence of 10 ng/ml
recombinant mouse IFN-c (Sigma-Aldrich). After 24 h, parasites
were added and NO release was measured 24 h later using Griess
reagent as described below. To assay interleukin-12 (IL-12),
peritoneal macrophages were cultured at 26105 cells per well in
24-well plates and incubated in the presence of 10 ng/ml
recombinant mouse IFN-c for 24 h, as previously described
[19]. Subsequently macrophages were stimulated with lipopoly-
saccharide (LPS, 20 ng/ml) and infected with Leishmania parasites
(L. pifanoi, L. major and L.infantum, parasite/cell ratio = 5:1). After
24 h, culture supernatants were harvested and IL-12 p40 secretion
was assayed by ELISA (BD Biosciences, Madrid, Spain), according
to the manufacturer’s instructions.
Generation of bone marrow-derived murine dendritic
cells (DCs)
We obtained bone marrow stem cell progenitors from the
femurs and tibiae of naı¨ve C57BL/6 mice and cultured the cells in
the presence of 20 ng/ml murine granulocyte macrophage colony-
stimulating factor (GM-CSF; PeproTech, London, UK), as
previously described [20]. We added fresh medium containing
GM-CSF to the cell cultures every 3 days, generating many
CD11c+ DCs largely free of granulocyte and monocyte contam-
ination. On day 7, DCs were plated at 16106 cells/ml in 6-well
plates and primed in the presence or absence of SLA (50 mg/ml).
DCs were collected at 24 h after pulsing with SLA and used for in
vitro stimulation of T cells as described below.
In vivo infections
Experimental CL was initiated by subcutaneous injection of
56103 metacyclic L. major promastigotes in 30 ml PBS into the left
footpad (at least 6 mice per group). Metacyclic forms had
previously been isolated from stationary cultures by negative
selection using peanut agglutinin (Vector Laboratories, Barcelona,
Spain) [21]. Footpad thickness was measured weekly with a metric
caliper. Draining lymph nodes (DLNs) and spleens from eutha-
nized mice were removed after 4 and 12 weeks of infection and
subjected to a limiting dilution assay.
Experimental VL was initiated by intravenous injection of
56105 L. infantum promastigotes in 100 ml PBS (at least 6 mice per
group). Spleens and livers from euthanized mice were removed
after 8 weeks of infection and subjected to a limiting dilution assay.
In addition, NO release, arginase activity, cytokine profile and
humoral response were determined in both CL and VL
experimental models, as described below.
Limiting dilution assay
Parasite burdens in DLNs, spleens and livers were determined
by limiting dilution culture [22]. Briefly, organs were harvested
aseptically and homogenized in 1 ml of Schneider’s medium
(Sigma-Aldrich) containing 20% FCS, streptomycin and penicillin.
Four-fold serial dilutions were carried out in 96-well culture plates
and incubated at 26uC. After culturing for 10 days, the highest
dilution yielding growth of viable Leishmania promastigotes was
determined using a phase contrast microscope.
Cytokine assay
Mice were infected as described above. At 4 weeks after L. major
infection, or 8 weeks after L. infantum infection, mice were
euthanized and single-cell suspensions of DLNs or spleens were
prepared, respectively. Previously, bone marrow-derived DCs
from naı¨ve C57BL/6 mice had been generated and pulsed with
SLA (50 mg/ml), as described above. T cells were washed,
resuspended at a final concentration of 26106 per ml in complete
Dulbecco’s modified Eagle’s medium (DMEM supplemented with
10% heat-inactivated FCS, 2 mM L-glutamine, 100 U/ml peni-
cillin, and 100 mg/ml streptomycin), and plated at 1 ml/well in
24-well plates. T cells and DCs were mixed at a ratio of 5:1 and
cultured for 72 h. Culture supernatants were harvested and
ELISA was used according to the manufacturer’s instructions to
assay secretion of the following mouse cytokines: IFN-c (Diaclone,
Madrid, Spain), IL-17 (R&D Systems, Madrid, Spain), IL-4
(eBioscience, Barcelona, Spain), IL-10 (Diaclone) and IL-13 (R&D
Systems).
NO assay
Concentration of nitrite, which is a byproduct of nitric oxide
(NO) production, was measured in the culture supernatant after
72 h using the Griess assay as described [23]. Briefly, 100 ml of
culture supernatant was mixed with an equal volume of Griess
reagent (Sigma-Aldrich) and incubated at room temperature for
10 min. Absorbance was then measured at 540 nm and nitrite
concentration calculated by comparison with a standard curve of
serial dilutions of sodium nitrite.
Arginase activity assay
After removing supernatants to measure NO release at 72 h,
cells were incubated for 30 min in lysis buffer (0.1 M Tris-HCl,
pH 7.5, 300 mM NaCl, 1 mM PMSF, 1% Triton X-100). Lysates
were then assayed for intracellular arginase activity as previously
described [24,25]. One unit of enzyme activity was defined as the
amount of enzyme that catalyzes the formation of 1 mmol of
urea/min.
Humoral immune response
Leishmania-specific antibodies were quantified by ELISA. Stan-
dard plates were coated overnight at 4uC with 100 mL of SLA
(4 mg/mL) diluted in PBS. Then wells were washed with PBS
supplemented with 0.05% (v/v) Tween-20 and blocked with 2%
(w/v) bovine serum albumin (BSA) in PBS. Sera were serially
diluted in order to determine the titer, which was defined as the
inverse of the highest serum dilution factor giving an absorbance
.0.2. Peroxidase-conjugated goat anti-mouse IgG1 and IgG2
were used as secondary antibodies (1:2500 and 1:500, respectively;
SouthernBiotech, Madrid, Spain). After washing and adding
peroxidase substrate (Ultra TMB-ELISA, ThermoScientific, Ma-
drid, Spain), the reactions were stopped with 2 M sulfuric acid.
Finally, sample absorbance was measured at 450 nm.
Statistical analysis
Since measurements showed a standard normal distribution,
Student’s t test was used to evaluate the significance of differences
between means of the experimental groups. Differences were
considered significant when P,0.05. Statistical analyses were
performed using SigmaPlot (version 12.2, Systat Software).
Results
In vitro studies of experimental leishmaniosis with
peritoneal macrophages from UCP2KO and WT C57BL/6
mice
In this study, in vitro results will be reported primarily for the
axenic Leishmania pifanoi amastigote line, whose similarity to the
Host UCP2, ROS Production and Leishmania Infection
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amastigotes isolated from infected macrophages has been exhaus-
tively demonstrated [26]. To investigate the ability of macrophag-
es from UCP2KO and WT mice to eliminate L. pifanoi amastigotes
in vitro, we determined infection rates in macrophages. As
demonstrated by confocal imaging (Fig. 1A), the percentage of
infected macrophages and the number of parasites per macro-
phage after 48 h were found to be lower in UCP2KO
macrophages than in WT ones (Fig. 1B–C). Our data showed
that the rate of superoxide formation in macrophages from
UCP2KO mice was higher than in those from WT mice. In
contrast, hydrogen peroxide levels seemed to be identical and did
not vary upon infection with L. pifanoi (Fig. 2).
Intracellular killing of Leishmania amastigotes by macrophages
requires production of both IL-12 and NO [27]. Therefore we
compared IL-12 and NO production in macrophages from
UCP2KO and WT mice following in vitro infection with L. pifanoi,
L. major or L. infantum. Peritoneal macrophages were primed with
IFN-c before the addition of LPS and parasites, as this is known to
be required for considerable production of IL-12 by macrophages
[28,29]. We observed that in vitro infection with any of the
Figure 1. Intracellular killing of L. pifanoi amastigotes by macrophages. To determine anti-leishmanial activity we seeded peritoneal
macrophages from WT and UCP2KO miceonto LabTek chamber slides at 56104 per chamber. After 4 h of infection with L. pifanoi amastigotes
labelled with CFSE (ratio 4:1), cells were washed until all free parasites were removed. (A) Confocal images were acquired 24 h later using a confocal
laser scanning microscope, and the infection rate was assessed by counting both (B) the percentage of infected macrophages and (C) the number of
parasites per infected macrophage. Asterisks indicate P,0.05 with respect to WT mice. (n = 6).
doi:10.1371/journal.pntd.0002077.g001
Host UCP2, ROS Production and Leishmania Infection
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Leishmania species did not suppress IL-12 p40 production. In
addition, IL-12 release revealed no significant difference between
peritoneal macrophages from UCP2KO and WT mice (Table 1).
In contrast, in vitro infection with any of the three Leishmania species
increased nitrite production in macrophages from UCP2KO mice
but not in macrophages from WT mice (Table 2).
Course of experimental CL in UCP2KO and WT C57BL/6
mice
Disease progression in mice infected with L. major was evaluated
by weekly monitoring of the appearance and extent of footpad
swelling. Infection led to significantly smaller footpad swelling
(after 6 weeks of infection) and lower parasite burden in DLNs in
UCP2KO mice than in WT mice (Fig. 3A, 3B). Lesions ultimately
resolved at the same time in both groups.
We also analyzed parasite loads in spleen in order to investigate
systemic infection. We did not detect L. major parasites in spleens of
UCP2KO mice after 12 weeks of infection (Fig. 3C), while 50% of
WT mice had not yet eliminated the parasites by this time. It is
important to point out that C57BL/6 mice are resistant to
cutaneous L. major infection and develop small, self-resolving
lesions [10].
Competition between arginase and iNOS enzymes in
phagocytic cells contributes to the outcome of L. major
infection
To investigate whether the increased resistance of UCP2KO
mice to L. major infection correlates with arginase and iNOS
activity, we measured arginase enzymatic activity and levels of
nitrite in the popliteal lymph nodes that were draining the
infection site after 4 weeks of infection. Arginase activity in the
draining popliteal lymph node was significantly lower in UCP2KO
mice than in WT mice (Fig. 3D). As expected, arginase activity
and NO production were undetectable in uninfected UCP2KO
and WT mice (data not shown). We also measured iNOS activity
indirectly by assaying nitrite production after stimulating DLN
Figure 2. ROS production. Levels of ROS in peritoneal macrophages isolated from UCP2KO and WT mice were estimated from the rate of
fluorescence increase of the cell-permeant redox-sensitive fluorescent indicators DHE and DCFDA. When required, 4 h before the determination,
macrophages were infected with L. pifanoi at a ratio 3:1. The rate of superoxide formation was estimated with the probe DHE (50 mM, excitation
535 nm, emission 610 nm) and the rate of hydrogen peroxide formation with the probe DCFDA (10 mM, excitation 485 nm, emission 535 nm).
Asterisks indicate P,0.05 with respect to WT mice. (n = 6).
doi:10.1371/journal.pntd.0002077.g002
Table 1. IL-12 secretion by elicited macrophages from peritoneum from WT and UCP2KO mice.
IL- 12 p40 (pg/ml)
Control Control IFN-c + LPS + IFN-c + LPS + IFN-c + LPS +
Medium IFN-c + LPS L. pifanoi 5:1 L. major 5:1 L. infantum 5:1
WT 25625 273648 243629 246634 244631
UCP2KO 31625 308634 264621 257628 283628
Macrophages were primed with IFN-c for 24 h and then challenged for another 24 h in the presence of LPS and parasites (ratio 5:1). Controls with medium only, or IFN-c
and LPS were included. After 24 h, culture supernatants were harvested. Data are presented as mean 6 S.D. (n = 6).
doi:10.1371/journal.pntd.0002077.t001
Host UCP2, ROS Production and Leishmania Infection
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cells with SLA-pulsed DCs. Nitrite levels were significantly higher
in DLN cells from UCP2KO mice than in DLN cells from WT
mice (Fig. 3E).
Humoral immune response and cytokine production in
UCP2KO and WT C57BL/6 mice infected with L. major
The Th1/Th2 paradigm of resistance/susceptibility to intra-
cellular infection is based largely on studies using L. major. Th1
cells secrete cytokines that promote cell-mediated immunity, while
Th2 cells secrete cytokines like IL-4 that induce antibody
production [30]. Leishmania is an intracellular pathogen that avoids
the humoral defenses of the host immune system. Thus, anti-
Leishmania IgG1 antibody production fails to protect against this
parasite and contributes to disease progression [31]. To charac-
terize the humoral immune response to L. major infection, we
measured levels of anti-SLA IgG1 and IgG2a antibodies in sera
from both groups of mice (Fig. 3F). Leishmania-specific IgG1
antibody levels were significantly lower in UCP2KO mice than in
WT mice after 4 and 12 weeks of infection. Nevertheless, the mean
Th1/Th2 humoral ratio after infection was similar between WT
and UCP2KO mice.
In order to determine what type of immune response is elicited
after L. major infection, we assayed IFN-c, IL-17 and IL-4
production in popliteal DLNs after in vitro stimulation with SLA-
pulsed DCs. After 4 weeks of infection, DLN cells of L. major-
infected UCP2KO mice produced significantly lower levels of
SLA-specific IL-4 than those of WT mice, but they produced
significantly larger amounts of SLA-specific IFN-c and IL-17
(Table 3).
Outcome of L. infantum infection in UCP2KO and WT
C57BL/6 mice
To investigate the effects of host UCP2 deficiency on L. infantum
systemic infection, we evaluated parasite loads in the spleen and
liver by limiting dilution after 8 weeks of infection. Parasite loads
in both organs were significantly smaller in infected UCP2KO
mice than in infected WT mice (Fig. 4A).
Humoral response and cytokine production in UCP2KO
and WT C57BL/6 mice infected with L. infantum
Anti-SLA IgG1 antibody levels were significantly lower in
UCP2KO mice than in WT mice after 4 and 12 weeks of
infection. However, IgG2a antibody levels were similar between
both groups of mice (Fig. 4B). To examine whether host UCP2
deficiency might play another role in the VL model, we evaluated
the pattern of cytokine production in the spleen in both groups of
mice. Spleens of UCP2KO mice showed significantly higher levels
of IFN-c and IL-13 than the spleens of WT mice (Table 4).
However, IL-10 levels were similar between the two groups of
mice.
Discussion
Since mitochondrial UCP2 has been proposed to negatively
regulate ROS levels and thereby help protect against oxidative
damage, we have decided to investigate the ability to mount
responses against Leishmania parasites in macrophages from
UCP2KO and WT mice. Protozoan parasites of the genus
Leishmania reside and replicate predominantly within macrophages,
cells involved in the innate immune response. It has recently been
suggested that Leishmania upregulates UCP2 after infection in order
to decrease host ROS levels and thereby suppress macrophage
defense machinery [9].
In agreement with previous studies using L. pifanoi [32], a
member of the Leishmania mexicana complex causing CL in the New
World [26], we consider that infection of macrophages with
axenically cultured L. pifanoi amastigotes represent a suitable in vitro
model to study mechanisms of phagocytic uptake, killing activity
and ROS production in mammalian cells. In laboratory experi-
ments (unpublished data), we found no significant differences in
the early phagocytosis, 2 h and 4 h after infection with L. pifanoi,
between UCP2KO and WT peritoneal macrophages. Neverthe-
less, we demonstrate here an enhanced resistance (Killing activity
at 24 h) of UCP2-deficient macrophages to infection with the
intracellular protozoan L. pifanoi. In addition to intracellular killing
of parasites, we assessed ROS production by peritoneal macro-
phages infected with L. pifanoi amastigotes, the intracellular form of
the mammalian stage of the parasite life. These results are of great
mechanistic importance since the activity of UCP2 should lower
superoxide formation at the mitochondrial respiratory chain [4].
Therefore, it suggests that mitochondrial ROS formation is an
important contributor to resistance of UCP2KO mice to L. pifanoi
infection and it would be in line with the reported resistance to
infection with Toxoplasma gondii [8]. We hypothesize that our results
reflect that natural synergy between increased ROS production
and increased nitrite production was greatly enhanced in
macrophages from UCP2KO mice. Several studies have ad-
dressed the role of ROS and NO in killing of Leishmania parasites
[33–35].
Our present work showed that thioglycollate-elicited macro-
phages population from peritoneum of both WT and UCP2KO
mice, stimulated by IFN-gamma and LPS, produced IL-12 p40
independently of Leishmania infection. Furthermore, none of the
three Leishmania species analyzed in our study (L. pifanoi, L. major or
L. infantum) was able to inhibit IL-12 p40 production by peritoneal
macrophages during the early stage of infection (24 h), as
characterized in previous studies [36]. The early induction and
maintenance of IL-12-dependent IFN-gamma production is
critical to the host resistance to Leishmania infection [36,37]. The
IFN-c induced production of NO is not only crucial for the direct
leishmanicidal activity of macrophages but also triggers the IL-12
signaling cascade that leads to further IFN-c production by natural
killer cells [38]. Regarding IL-12 production, it has been suggested
that Leishmania parasites of different species are potent inhibitors of
macrophage IL-12 production [29,39,40]. However, the ability of
macrophages to produce IL-12 seems to be related to their
maturation stage [36,41]. Also, this capacity varies depending on
the stage of Leishmania infection [36]. We found NO, a principal
effector molecule that mediates the intracellular killing of
Leishmania parasites [42], to be present at higher levels in
UCP2KO peritoneal macrophages than in WT ones after
Table 2. Nitrite production.
Nitrites (mM)
Control L. pifanoi L. major L. infantum
WT 1262 1362 1462 1562
UCP2KO 1763 1963 (*) 2062 (*) 2563 (*)
The NO production was indirectly determined by measuring nitrite level in the
cultured supernatant by Griess reaction at 24 h after infection. Control:
uninfected mice. Data are presented as mean 6 S.D. (n = 6). Asterisks indicate
P,0.05 with respect to WT macrophages.
doi:10.1371/journal.pntd.0002077.t002
Host UCP2, ROS Production and Leishmania Infection
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Figure 3. UCP2KO mice display enhanced resistance to CL. UCP2KO and WT C57BL/6 mice were challenged subcutaneously with 56103 L.
major metacyclic promastigotes and the course of infection was evaluated. A. Mean diameter of induration (6 S.D) in the footpad at various times
after infection. B. Mean number of parasites per popliteal DLN (6 S.D) at 4 and 12 weeks after infection. C. Mean number of parasites per spleen (6
S.D) at 4 and 12 weeks after infection. D–E. Competition between arginase and iNOS (nitrite levels) enzymes in DLNs was assessed at 4 and 12 weeks
after L. major infection. Single cell suspensions of DLNs from euthanized mice were cultured for 72 h in the presence of SLA-pulsed DCs. Arginase
activity was measured in cell lysates and nitrite levels were measured in the culture supernatants. F. Anti-SLA antibody (IgG1 and IgG2a) titers in sera
from WT and UCP2KO mice at 4 and 12 weeks after infection. Data are presented as mean 6 S.D. (n = 6). N.D., parasites not detected. Asterisks
indicate P,0.05 with respect to WT mice.
doi:10.1371/journal.pntd.0002077.g003
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infection with any of three Leishmania species. Therefore, our study
provides in vitro evidence that macrophages from UCP2KO mice
have developed several mechanisms to combat intracellular
Leishmania pathogens more efficiently. These include not only
maintenance of IL-12 p40 production throughout infection that is
required to prevent the loss of Th1 cells [37], but also significant
high amounts of ROS and NO after Leishmania infection.
Subsequently we found that UCP2KO C57BL/6 mice mounted
a stronger host defense against L. major and L. infantum infections in
vivo than did the corresponding WT mice. In contrast to BALB/c
mice, C57BL/6 mice after L. major infection develop self-healing
cutaneous lesions and control parasite multiplication [43]. It has
been reported that CL in C57BL/6 mice occurs in two phases
following infection in the ear: a remarkably silent phase lasting
about 4 weeks favors parasite amplification in the dermis without
the formation of a lesion, followed by the development of a
cutaneous lesion that coincides with a reduction in parasite load at
the site of infection [44]. In our study mice were inoculated in the
footpad and the evolution of infection occurred in the two
mentioned phases above. UCP2KO C57BL/6 mice were signif-
icantly better than their WT counterparts at controlling L. major:
after 6 weeks of infection, the UCP2KO mice showed significantly
smaller footpad swelling and lower parasite burden. Nevertheless,
the lesions in the UCP2KO mice resolved at the same time as
those in WT mice, suggesting that lack of UCP2 accelerated the
development of an adaptive immune response at the level of
parasite load but not at the level of lesion resolution. This may
reflect the intrinsic features of the resistant C57BL/6 strain, which,
like humans, develops self-healing skin lesions following L. major
infection [45,46]. Taken together, our data showed that UCP2
deficiency was dispensable for the resolution of the lesions at the
site of infection, but was advantageous to achieve an early
reduction of parasite load in the DLN and was essential for
efficient parasite clearance in the spleen after 12 weeks p.i. These
results are consistent with previous research showing that the
capacity to kill intracellular L. major parasites was dramatically
reduced in mice deficient in the production of reactive oxygen
intermediates (ROI) [34]. In addition, it is well established that
NO acts as a leishmanicidal molecule [42], interfering with
arginase activity in infected host cells and subsequently with
cellular metabolism of Leishmania. Inhibition of arginase activity
during infection has a clear therapeutic effect, as evidenced by
markedly reduced pathology and efficient control of parasite
replication [47]. In the present study, arginase activity was lower
and leishmanicidal nitrite levels were higher in phagocytic cells
from UCP2KO mice than in such cells from WT mice. This
reflects greater intracellular killing of Leishmania parasites in
UCP2KO mice.
Because susceptibility to Leishmania infection correlates with the
development of CD4+ Th2 cells, whereas resistance correlates with
the development of CD4+ Th1 cells [43], we compared the
production of the cytokines IFN-c, IL-17 and IL-4 in DLNs from
L. major-infected UCP2KO and WT mice after in vitro stimulation
with SLA-pulsed DCs. We found that infected UCP2KO mice
showed a higher Th1 and Th17 anti-Leishmania immune response
and a weaker Th2 response than did WT mice. Consistent with
our findings, UCP2KO mice infected with another intracellular
pathogen, Listeria monocytogenes, showed high levels of ROS in the
spleen, and this was associated with a switch away from anti-
inflammatory cytokine production toward proinflammatory cyto-
Table 3. Cytokine production in mice infected with L. major
at 4 weeks after infection.
pg/ml
IFN-c IL- 17 IL- 4
WT 7376150 238650 85610
UCP2KO 11626150 (*) 442650 (*) 43610 (*)
Data are presented as mean 6 S.D. (n = 6). Asterisks indicate P,0.05 with
respect to WT mice.
doi:10.1371/journal.pntd.0002077.t003
Figure 4. Outcome of visceral infection in UCP2KO and WT
C57BL/6 mice. All mice were challenged intravenously with 56105
live, stationary-phase L. infantum parasites, and spleens, livers and sera
were harvested at 8 weeks after infection. A. UCP2KO mice reduce
parasite loads (assessed by limiting dilution) in spleen and liver more
efficiently than WT mice. B. Anti-SLA antibody (IgG1 and IgG2a) titers
were determined by ELISA. Data are presented as mean 6 S.D. (n = 6).
Asterisks indicate P,0.05 with respect to WT mice.
doi:10.1371/journal.pntd.0002077.g004
Table 4. Cytokine production in mice infected with L.
infantum at 8 weeks after infection.
pg/ml
IFN-c IL- 13 IL- 10
WT 5526100 241620 69620
UCP2KO 7966100 (*) 325620 (*) 82620
Data are presented as mean 6 S.D. (n = 6). Asterisks indicate P,0.05 with
respect to WT mice.
doi:10.1371/journal.pntd.0002077.t004
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kine production, as well as with a significant increase in recruited
splenic phagocytes [7]. We further found UCP2KO mice to have
elevated IL-17 levels, which is consistent with previous reports that
acquisition of a resistant phenotype in both VL and CL murine
models is related to Th1- and Th17-mediated, parasite-specific
cellular responses [48,49].
In addition, we assessed the relative production of IgG2a and
IgG1 isotypes, since these have been widely used as markers,
respectively, of the induction of Th1- and Th2-type immune
responses [50]. Indeed, anti-Leishmania IgG1 antibody production
fails to protect against this intracellular pathogen and contributes
to disease progression [31]. In accordance with the notion that
UCP2KO mice are highly resistant to Leishmania infection, we
found not only higher levels of Leishmania-specific IgG1 antibodies
in WT mice than UCP2-deficient ones, but also higher IL-4 levels
in DLNs from WT mice. Th2 IL-4 cytokine has been reported to
induce antibody production [30]. Taken together, these data
support our hypothesis that UCP2KO mice have developed
increased resistance to L. major that led to a faster resolution of the
infection.
The visceral form of the disease (VL) was also evaluated in order
to investigate the role of UCP2 in host immune defense. C57BL/6
and BALB/c strains of mice susceptible to L. infantum infection
possess a non-functional Slc11a1 gene, preventing them from
controlling early parasite growth in the liver [21,51,52]. However,
during later stages of L. infantum infection, these strains develop
mature granulomas that can eliminate the parasites in the liver
[53,54]. It has been reported that while ROS are not crucial for
the activation of leishmanicidal abilities of hepatic mature
granulomas during later stages of VL, NO and ROS do contribute
to parasite control [33]. A recent study of murine VL reported that
granuloma maturation is delayed in mice deficient in IL-13 due to
defective IFN-c production and elevated IL-4 and IL-10 levels
[55]. That study suggested that IL-13 plays a crucial role in
ensuring efficient hepatic granuloma maturation to control
parasite load during VL [55]. Therefore we evaluated the pattern
of cytokine production by the spleen in UCP2KO and WT mice in
the present study. Our finding that IFN-c and IL-13 levels in the
spleen were significantly higher in UCP2KO mice supports the
notion that they are better able to control L. infantum infection.
This is consistent with a recent study in which siRNA-mediated
silencing of the UCP2 gene in a mouse model of VL stimulated
mitochondrial ROS production, which induced a proinflamma-
tory cytokine response and subsequently reduced parasite burden
[9]. Also, anti-Leishmania IgG1 antibody production, associated
with increased susceptibility to the disease as mentioned above,
was significant higher in WT mice as compared to UCP2-deficient
ones.
In conclusion, our study for the first time provided in vivo
evidence that UCP2 deficiency was beneficial to achieve an early
control of parasite growth in the DLN and was critical to avoid
visceralization of the parasite during CL. Also, it does contribute
to parasite control in murine model of VL. The role of UCP2 as
part of the cellular anti-oxidant defence is well established. Since
alterations in UCP2 levels are involved in a number of pathologies,
this protein is currently considered as a drug target [2]. A good
example comes from the cancer field and, thus, it has been shown
that UCP2 levels are elevated in drug-resistant tumour cells and
that UCP2 inhibitors sensitize cancer cells to chemotherapeutic
agents [3]. In our work, we demonstrate that knock-out of the
UCP2 gene allows mice to respond better to CL and VL.
Therefore, it can be envisaged that UCP2 inhibitors may improve
efficacy of combined therapies against leishmaniosis.
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